Gene therapy proves effective for hemophilia B

2011-12-10T19:30:13Z

SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B.

Researchers said the same technology was also being studied as a treatment for hemophilia A, the fa...

FDA panel gives nod to Affymax drug for anemia

2011-12-07T15:30:28Z

SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.

A Food and Drug Admini...

Amgen signs DaVita, Fresenius anemia drug deals

2011-11-18T16:00:12Z

(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.

The biotechnology company said in a reg...

Amgen signs 7-year anemia drug contract with DaVita

2011-11-18T11:00:21Z

(Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market for its flagship drug Epoge...

Medicare confirms changes in anemia drug use

2011-11-01T16:30:13Z

LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of CHICAGO (Reuters) - U.S. scientists have found a way to get mice with a form of sickle cell disease to make normal red blood cells, offering a potential new way to treat the blood disorder in people, they reported on Thursday.

Adults with sickle cell disease make mutant, sickle-shaped forms of hemoglobin, the protein in red blood cel...

Medicare proposes change in anemia drug usage

2011-07-01T22:00:06Z

LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of

Incyte, Novartis myelofibrosis trial meets goal

2011-06-04T12:00:07Z

CHICAGO (Reuters) - A second pivotal trial of ruxolitinib, developed by Incyte Corp and Novartis, met its goal of showing that the drug significantly reduces spleen size in myelofibrosis patients.

The rare, but po...

Common drug helps babies with sickle cell disease

2011-05-12T16:00:11Z

CHICAGO (Reuters) - A drug that eases symptoms of sickle cell disease in older children is safe and effective to use for babies with the blood disorder and should become the new standard of care, U.S. researchers said on Thursday.

They said the generic drug hydroxyurea significantly reduced pain and other common complications in babi...

Bahrain activist dies in jail: ministry

2011-04-03T16:30:44Z

A detainee held in connection with anti-regime protests in Bahrain died in prison on Sunday, the Gulf state's interior ministry said in a statement.

"A detainee who was a sickle cell patient died on Sunday morning at the detention centre," it said. The ministry's website identified the man as Hasan Jasem Makki, 39.

A ministry official said a prison doctor "gave him the required medicine for sickle cell," a genetic blood disorder, ...

Medicare proposes no changes for anemia drugs

2011-03-16T15:00:10Z

LOS ANGELES (Reuters) - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.

The agency, which is slated to issue a final decision on the matter in June, also said it has found no clear p...

Novartis sees blood cancer drug as blockbuster

2011-03-15T11:00:14Z

ZURICH (Reuters) - Novartis AG's blood cancer drug INC424 could rake in annual sales of $1 billion, the group's head of oncology told Reuters on Tuesday, in a boost to the Swiss drugmaker's cancer pipeline.

"We believe it can become a very reasonable commercial opportunity" said Herve Hoppenot, president of Novartis Oncology....

Biogen to build blood disorder drug franchise

2011-03-04T09:00:08Z

BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood d...

France sees first 'saviour sibling'

2011-02-07T19:30:16Z

Doctors in France on Monday announced the country's first birth of a "saviour sibling," selected at the embryonic stage to be a close genetic match to save a brother or sister suffering from a fatal inherited disorder.

The baby was born at the Antoine Beclere Hospital in Clamart, in the suburbs of Paris, said doctors Rene Frydman and Arnold Munnich.

The child, born to parents of Tu...

Amag Shares Rise As Feraheme Agreement Announced

2010-11-29T14:35:15Z

...

How to Donate Plasma for Money in Fort Worth

2010-11-29T14:36:51Z

...

Study Published in New England Journal of Medicine Shows Nplate Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP

2010-11-29T14:35:05Z

...

Renal medullary carcinoma

2010-11-30T13:48:52Z

...

Aafact

2010-11-30T13:48:16Z

...

Sickle Cell Anemia

2010-11-30T13:49:04Z

...

Thalassemia

2010-11-30T13:49:18Z

...

Twinkle Dwivedi

2010-11-30T13:49:27Z

...

Von Willebrand Disease

2010-11-30T13:49:33Z

...

Hemoglobin Abnormalities

2010-11-29T14:36:13Z

...

Romiplostim Beats Usual Care for Immune Thrombocytopenia

2010-11-29T14:46:37Z

...

Effective control of sickle cell disease with hydroxyurea therapy

2010-11-29T14:57:07Z

...

Overview of hemolytic anemias

2010-11-29T15:49:24Z

...

Social statistics: What is a base rate fallacy?

2010-11-29T15:50:44Z

...

SIR WILLIAM WHITLAS FAMILY NAME

2010-11-29T14:55:29Z

...

EMBOLIC STROKE AS A LATE COMPLICATION OF INFERIOR VENA CAVA THROMBOSIS

2010-11-29T14:55:29Z

...

Study of Possible Genetic Factors Determining the Clinical Picture of Thalassemia Intermedia

2010-11-29T14:55:15Z

...

Prevalence of Anemia and Related Risk Factors Among 411 Months Age Infants in Eskisehir Turkey

2010-11-29T14:55:11Z

...

YM Biosciences Reports Significant Response Rates in Anemia, Splenomegaly, and Constitutional Symptoms From the Phase I/Ii Trial of Its Jak1/Jak2 Inhibitor, Cyt387, in Myelofibrosis

2010-11-29T14:34:59Z

...

Boot Camp Death

2010-11-30T13:25:48Z

...

What Is a CBC Lab Test?

2010-11-29T14:35:53Z

...

What Are TTP and ITP?

2010-11-29T14:35:44Z

...

Overview of types of anemia

2010-11-29T15:17:40Z

...

Foods that may help in the treatment of anemia

2010-11-29T15:13:17Z

...

Anemia: Symptoms and treatment

2010-11-29T15:16:15Z

...

How bartonellosis is diagnosed and treated

2010-11-29T15:15:50Z

...

Overview of liver function tests

2010-11-29T15:15:52Z

...

Oral health: Overview of stomatitis

2010-11-29T15:13:37Z

...

Chemotherapy Scans

2010-08-27T13:00:46Z

This image, provided by The University of Wisconsin, Section of Hematology & Medical Oncology and taken from a FLT-PET scan of a 47-year old woman, shows that leukemia present in the bone marrow before treatment, left, persisted after chemotherapy, right. (AP Photo/The University of Wisconsin, Section of Hematology & Medical Oncology)

HealthBeat Sickle Cell

2010-04-05T11:44:47Z

In this Aug. 1, 2009 photo, Andrea Williams, Executive Director of the Children's Sickle Cell Foundation sits with her son Jonathan, 9, who has Sickle Cell disease, as he holds a piece of red candy Williams uses to represent a child with sickle cell disease in a game she developed called the candy-gene game in Pi...

San Diego California News - January 09, 2009

2010-04-09T17:53:04Z

January 10, 2009,-San Diego, CA,-Mt. Carmel High School surf team member TUCKER HALL is the survivor of a rare blood disease called blackfan diamond anemia

...

About Blood Disorders